1 Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Feb 22, 2025
Read More Medical Approved! With Just One Oral Dose Per Day, This Type Of Breast Cancer Patient Gets a New Drug Apr 05, 2025